Viropharma Inc (VPHM) Gross Profit Margin starting from the third quarter 2013 to third quarter 2012, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Viropharma Inc  (VPHM)


Viropharma Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VPHM Gross Profit Margin (Sep 30 2013)
Q3 		(Jun 30 2013)
Q2 		(Mar 31 2013)
Q1 		(Dec 31 2012)
Q4 		(Sep 30 2012)
Q3
Y / Y Revenue Change 24.24 %
Seq. Revenue Change 9.02 %
Revenue In Millions $113.06
Gross Profit Margin 75.7 %
Gross Profit Margin Total Ranking # 537
Gross Profit In Millions $85.58
Y / Y Gross Profit Change 23.23 %
Seq. Gross Profit Change 13.28 %


Commenting Third Quarter 2013 Gross Profit Margin
Viropharma Inc Gross Profit grew by 13.28 % in Q3 sequentially to 86 millions, while Revenue increased by 9.02 %, this led to improvement in the company's Gross Profit Margin to 75.7 %, above the Viropharma Inc average Gross Profit Margin.


Observing third quarter 2013 results within Biotechnology & Pharmaceuticals industry 12 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 537, from total ranking in the previous quarter at 611.
Learn about Gross Margin
VPHM's Gross Profit Margin third quarter 2013 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 72
Overall # 442

Gross Profit Margin Statistics
High Average Low
76.32 % 74.61 % 72.85 %
(Sep 30 2012)   (Jun 30 2013)


VPHM Gross Income Trends • More of VPHM's Profitabilty Ratios • VPHM Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
VPHM's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
VPHM's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for VPHM's Competitors
Gross Profit Margin Profit Margin for Viropharma Inc's Suppliers
Gross Profit Margin Profit Margin for VPHM's Customers

You may also want to know
VPHM's Annual Growth Rates VPHM's Profitability Ratios VPHM's Asset Turnover Ratio VPHM's Dividend Growth
VPHM's Roe VPHM's Valuation Ratios VPHM's Financial Strength Ratios VPHM's Gross Profit Growth
VPHM's Roa VPHM's Inventory Turnover Ratio VPHM's Growth Rates VPHM's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2013, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginSep 30 2013 MRQ Gross ProfitSep 30 2013 MRQ Revenue
Pluri Inc   96.84 %$ 0.092  Millions$ 0.095  Millions
Halozyme Therapeutics Inc   95.74 %$ 15.330  Millions$ 16.013  Millions
Cellular Biomedicine Group Inc   95.04 %$ 3.030  Millions$ 3.188  Millions
Seagen Inc   95.03 %$ 67.441  Millions$ 70.969  Millions
Exelixis Inc   94.69 %$ 5.176  Millions$ 5.466  Millions
Agenus Inc  89.12 %$ 0.656  Millions$ 0.736  Millions
Biogen Inc   87.16 %$ 1,593.084  Millions$ 1,827.780  Millions
Amgen Inc   83.40 %$ 3,960.000  Millions$ 4,748.000  Millions
Nutrastar International Inc.  80.26 %$ 8.777  Millions$ 10.936  Millions
Acorda Therapeutics Inc   79.73 %$ 67.706  Millions$ 84.919  Millions
Protalix Biotherapeutics inc   77.58 %$ 1.772  Millions$ 2.284  Millions
Bohai Pharmaceuticals Group, Inc.  76.99 %$ 39.181  Millions$ 50.889  Millions
Viropharma Inc  75.70 %$ 85.583  Millions$ 113.062  Millions
Gilead Sciences Inc   75.50 %$ 2,100.965  Millions$ 2,782.833  Millions
Bio techne Corp  71.34 %$ 61.114  Millions$ 85.668  Millions
Lineage Cell Therapeutics Inc   71.06 %$ 0.507  Millions$ 0.714  Millions
China Biologic Products Holdings Inc   67.70 %$ 35.986  Millions$ 53.152  Millions
Repligen Corp  66.08 %$ 12.438  Millions$ 18.822  Millions
Cadence Pharmaceuticals Inc  65.59 %$ 18.993  Millions$ 28.957  Millions
Enzo Biochem Inc  59.77 %$ 14.425  Millions$ 24.134  Millions
Xtant Medical Holdings Inc   58.15 %$ 4.612  Millions$ 7.930  Millions
Beam Therapeutics Inc   57.36 %$ 343.400  Millions$ 598.700  Millions
Ds Healthcare Group, Inc.  55.07 %$ 1.762  Millions$ 3.200  Millions
Nanostring Technologies Inc   54.89 %$ 4.605  Millions$ 8.389  Millions
Novavax inc   52.60 %$ 2.526  Millions$ 4.802  Millions
Noho, Inc.  46.55 %$ 0.079  Millions$ 0.170  Millions
Dendreon Corp  30.98 %$ 21.069  Millions$ 68.002  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.